TY  - GEN
AU  - Chen,Chun-Hsien
AU  - Chen,Chien-Hung
AU  - Lin,Chih-Lang
AU  - Lin,Chun-Yen
AU  - Hu,Tsung-Hui
AU  - Tung,Shui-Yi
AU  - Hsieh,Sen-Yung
AU  - Lu,Sheng-Nan
AU  - Chien,Rong-Nan
AU  - Hung,Chao-Hung
AU  - Sheen,I-Shyan
TI  - Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysis
SN  - 2045-2322
PY  - 2020///1027
KW  - 2-Naphthylamine
KW  - Aged
KW  - Anilides
KW  - adverse effects
KW  - Antiviral Agents
KW  - therapeutic use
KW  - Carbamates
KW  - Cyclopropanes
KW  - Drug Therapy, Combination
KW  - Female
KW  - Genotype
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C, Chronic
KW  - complications
KW  - Humans
KW  - Lactams, Macrocyclic
KW  - Liver Cirrhosis
KW  - Macrocyclic Compounds
KW  - Male
KW  - Middle Aged
KW  - Proline
KW  - analogs & derivatives
KW  - Retrospective Studies
KW  - Ribavirin
KW  - Ritonavir
KW  - Sulfonamides
KW  - Sustained Virologic Response
KW  - Uracil
KW  - Valine
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1038/s41598-019-43554-3
ER  -